Scope
Reference
DACPM2025-23
Description
Procurement of RISANKIZUMAB 360MG SOLUTION FOR INJECTION HOMECARE
Contract 1. RISANKIZUMAB 360MG SOLUTION FOR INJECTION HOMECARE
Supplier
Contract value
- £640,000 excluding VAT
- £640,000 including VAT
Above the relevant threshold
Date signed
3 June 2025
Contract dates
- 3 June 2025 to 30 June 2027
- 2 years, 28 days
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Contract locations
- UKN - Northern Ireland
Justification for not setting key performance indicators
Contract value is below the relevant threshold for Key performance indicators
Other information
Applicable trade agreements
- Government Procurement Agreement (GPA)
Conflicts assessment prepared/revised
Yes
Procedure
Procedure type
Direct award
Direct award justification
Additional or repeat goods, services or works - extension or partial replacement
These essential medicines are required from this supplier to ensure continuity of patient care, specifically for homecare support. The absence of competition is not the artificial narrowing of the parameters of the procurement
Supplier
SCIENSUS PHARMA SERVICES LIMITED
- Companies House: 02759609
- Public Procurement Organisation Number: PXLC-2487-LQPH
107 Station Street
Burton-On-Trent
DE14 1SZ
United Kingdom
Email: bidsandtenders@sciensus.com
Website: http://www.sciensus.com
Region: UKG24 - Staffordshire CC
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Contract 1. RISANKIZUMAB 360MG SOLUTION FOR INJECTION HOMECARE
Contracting authority
Belfast Health & Social Care Trust
- Public Procurement Organisation Number: PLQJ-5727-JCLR
Trust Headquarters, 2nd Floor, Non Clinical Support Building, Royal Victoria Hospital
Belfast
BT12 6BA
United Kingdom
Region: UKN06 - Belfast
Organisation type: Public authority - central government
Devolved regulations that apply: Northern Ireland